Gates Foundation Works With China Drug Agency to Raise Standards
- More gold-standard regulators needed besides FDA, EMA: Gates
- Microsoft founder speaks on health panel in Davos, Switzerland
An employee examines vials of adrenaline hydrochloride injection solution at a China Grand Pharmaceutical and Healthcare Holdings Ltd. facility in Wuhan, China, on Tuesday, June 13, 2017.
Photographer: Qilai Shen/BloombergThe Bill & Melinda Gates Foundation is working with China’s health agency to help authorities there improve their standards, potentially creating a challenger to the world’s two most powerful regulators, billionaire Bill Gates said.
The U.S. and European regulatory dominance sometimes leads other agencies to reject medicines or vaccines that could have served a purpose in their own nations, Gates said at a panel discussion at the World Economic Forum in Davos, Switzerland. His foundation, which has spent about $12 billion on projects to improve global health in the last five years, has former employees of the U.S. Food and Drug Administration working to help the Chinese Food and Drug Administration, he said.